Ad is loading...
MIINX
Price
$15.13
Change
-$0.08 (-0.53%)
Updated
Nov 15 closing price
VTSNX
Price
$129.61
Change
-$0.62 (-0.48%)
Updated
Nov 15 closing price
Ad is loading...

MIINX vs VTSNX

Header iconMIINX vs VTSNX Comparison
Open Charts MIINX vs VTSNXBanner chart's image
BNY Mellon International I
Price$15.13
Change-$0.08 (-0.53%)
VolumeN/A
CapitalizationN/A
Vanguard Total Intl Stock Index I
Price$129.61
Change-$0.62 (-0.48%)
VolumeN/A
CapitalizationN/A
MIINX vs VTSNX Comparison Chart
Loading...
View a ticker or compare two or three
VS
MIINX vs. VTSNX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MIINX is a Sell and VTSNX is a Buy.

FUNDAMENTALS
Fundamentals
VTSNX has more cash in the bank: 442B vs. MIINX (228M). VTSNX (3.29) and MIINX (3.15) have matching dividends . MIINX was incepted earlier than VTSNX: MIINX (23 years) vs VTSNX (14 years). MIINX is a more actively managed with annual turnover of: 63.06 vs. VTSNX (4.00). MIINX has a lower initial minimum investment than VTSNX: MIINX (10000) vs VTSNX (5000000). VTSNX annual gain was more profitable for investors over the last year : 10.92 vs. MIINX (9.74). MIINX return over 5 years is better than : 16.86 vs. VTSNX (15.91).
MIINXVTSNXMIINX / VTSNX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence23 years14 years-
Gain YTD2.0924.53546%
Front LoadN/AN/A-
Min. Initial Investment1000050000000%
Min. Initial Investment IRAN/AN/A-
Net Assets228M442B0%
Annual Yield % from dividends3.153.2996%
Returns for 1 year9.7410.9289%
Returns for 3 years-3.22-5.8655%
Returns for 5 years16.8615.91106%
Returns for 10 years28.9829.8197%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CLSK14.030.05
+0.36%
CleanSpark
BSRR31.33-0.19
-0.60%
Sierra Bancorp
GEHC81.76-1.16
-1.40%
GE HealthCare Technologies
NXTC1.31-0.03
-2.24%
NextCure
RCKT13.98-0.84
-5.67%
Rocket Pharmaceuticals